Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

Ignota Labs is using AI to fix failed drugs and bring them to market. It raised $6.9 million from investors with this pitch ...

The hottest trend on the horizon for artificial intelligence (AI) is agentic AI, according to Jason Moore, Ph.D., chair of ...

We didn’t start Model to launch a company—we started it because no one else met our standards,” says Dr. Daniel Haders II, CEO and founder of Model Medicines. On this episode of Vanguards of Health ...

The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...

Scientists have developed a revolutionary AI "fingerprint" technology that can accurately show how cancer cells respond to ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

One of the most promising applications of AI in emergency medicine is medical imaging analysis. AI-driven tools are being ...

The nonpartisan advert encourages the public to get involved in local town halls and to be civil with peers. Images of the ...

While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...

JERUSALEM, April 1 (Xinhua) -- Israeli researchers have developed scNET, an AI tool that analyzes how cells behave in changing biological environments, including their reactions to drug treatments, ...